Clinicopathologic profile of gestational trophoblastic disease.
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 115 (1) , 29-35
- https://doi.org/10.1007/bf03040269
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Expression of Epidermal Growth Factor Receptor-Related Family Products in Gestational Trophoblastic Diseases and Normal Placenta and Its Relationship with Development of Postmolar TumorGynecologic Oncology, 2000
- Expression of the p53 Gene and Apoptosis in Gestational Trophoblastic DiseasePlacenta, 2000
- p53, PCNA, and Ki-67 in Hydropic Molar and Nonmolar PlacentasInternational Journal of Gynecological Pathology, 1996
- Amplification and Expression of the C-erbB-2 Oncogene in Normal, Hyperplastic, and Malignant EndometriaInternational Journal of Gynecological Pathology, 1995
- DNA cytometric and interphase cytogenetic analyses of paraffin‐embedded hydatidiform moles and hydropic abortionsThe Journal of Pathology, 1993
- DNA content as a prognostic index in gestational trophoblastic neoplasiaGynecologic Oncology, 1989
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Flow cytometry in persistent trophoblastic diseasePlacenta, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185Cell, 1986